Loading...
Efficacy and safety of different doses of evolocumab in reducing low-density lipoprotein cholesterol levels: A meta-analysis
Evolocumab has been considered as an efficacious, safe and promising therapeutic modality for hypercholesterolemia and is associated with cardiovascular diseases. The efficacy and safety of two different doses of evolocumab were evaluated and the safety of evolocumab was compared with that of a plac...
Na minha lista:
| Udgivet i: | Biomed Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5103663/ https://ncbi.nlm.nih.gov/pubmed/27882214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.766 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|